Abilify is an atypical antipsychotic medication used primarily to treat schizophrenia and related mood disorders. It is classified as a partial agonist at dopamine d2 receptors and also stimulates serotonin 5ht1a receptors while blocking 5ht2a receptors. This dual receptor activity helps modulate neurotransmitter transmission in pathways associated with psychosis and depression. The drug is formulated as oral tablets that are absorbed in the gastrointestinal tract and metabolized mainly by hepatic enzymes. The resulting metabolites are eliminated primarily through the kidneys with a minor portion excreted unchanged in urine. The combined mechanisms of partial agonism and receptor modulation produce its clinically observed therapeutic effects.

Abilify is an atypical antipsychotic medication approved for treating certain psychiatric disorders. Its therapeutic purpose is to manage symptoms such as psychosis, mood instability, and irritability associated with conditions like schizophrenia and bipolar disorder. The drug acts primarily as a partial agonist at dopamine d2 receptors, providing modulated stimulation of these receptors under conditions of overactivity and underactivity. It also partially activates serotonin 5-ht1a receptors, contributing to antipsychotic and antidepressant effects. Through these actions the medication stabilizes neural circuits involved in mood and perception, leading to reduced hallucinations and improved emotional regulation. The resulting pharmacological profile supports its clinical use as an add-on therapy or standalone treatment for the aforementioned conditions.

Common side effects of Abilify may include nausea, weight gain, and drowsiness. Some users experience restlessness or a feeling of inner tension. Others report changes in appetite or mild headaches. Occasionally, visual disturbances such as blurred vision have been reported. Sleep disturbances like insomnia or increased sleepiness can occur. A small number of people experience mild shaking of the hands. Elevations in blood sugar levels have been noted in rare cases. Fatigue or low energy may also be observed.

Common side effects of Abilify often include nausea and occasional vomiting. Some people experience headaches or dizziness while taking the medication. Restlessness or an inability to sit still known as akathisia can also occur. Sleep disturbances such as insomnia or excessive sleepiness may be observed. Weight gain and increased appetite are reported by a portion of users. Constipation and mild gastrointestinal discomfort are frequently noted. Anxiety and tremor are additional reactions that have been documented.